Kujin suppresses histamine signaling at the transcriptional level in toluene 2,4-diisocyanate-sensitized rats

Journal of Pharmacological Sciences

Volumn 109, Issue 4, 2009, Pages 606-617

  Dev, Shrabanti ^a   Mizuguchi, Hiroyuki ^a   Das, Asish K ^a   Maeyama, Kazutaka ^b   Horinaga, Shiho ^a   Kato, Shuhei ^a   Tamada, Misaki ^a   Hattori, Masashi ^a   Umehara, Hayato ^a   Fukui, Hiroyuki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

Allergy; Histamine H1 receptor; Histamine signaling; Histidine decarboxylase; Kujin

Indexed keywords

ANTIALLERGIC AGENT; CYTOKINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTIDINE DECARBOXYLASE; INTERLEUKIN 4; INTERLEUKIN 5; KUJIN EXTRACT; MEPYRAMINE; MESSENGER RNA; PLANT EXTRACT; TOLUENE DIISOCYANATE; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; KUJIN; MALE; NONHUMAN; NOSE MUCOSA; PROVOCATION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TH2 CELL;

EID: 66249133939     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09003FP     Document Type: Article

References (74)

1. Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod. 1999;62:1595-1599.
2. Sohn HY, Son KH, Kwon CS, Kwon GS, Kang SS. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine. 2004; 11:666-672.
3. Kim DW, Chi YS, Son KH, Chang HW, Kim JS, Kang SS, et al. Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescens, on cyclooxygenase-2 and in vivo inflammatory response. Arch Pharm Res. 2002;25:329-335.
4. Kwon KB, Kim EK, Lim JG, Shin BC, Song YS, Seo EA, et al. Sophorae radix extract inhibits high glucose-induced vascular cell adhesion molecule-1 up-regulation on endothelial cell line. Clin Chim Acta. 2004;348:79-86.
5. Hoang BX, Shaw DG, Levine S, Hoang C, Pham P. New approach in asthma treatment using excitatory modulator. Phytother Res. 2007;21:554-557.
6. Sun M, Han J, Duan J, Cui Y, Wang T, Zhang W, et al. Novel antitumor activities of Kushen flavonoids In Vitro and In Vivo. Phytother Res. 2007;21:269-277.
7. Tsai JC, Tsai S, Chang WC. Effect of ethanol extracts of three Chinese medicinal plants with anti-diarrheal properties on ion transport of the rat intestinal epithelia. J Pharmacol Sci. 2004;94:60-66.
8. Kim YC, Kim HS, Wataya Y, Sohn DH, Kang TH, Kim MS, et al. Antimalarial activity of lavandulyl flavanones isolated from the roots of Sophora flavescens. Biol Pharm Bull. 2004;27:748-750.
9. Liu J, Zhu M, Shi R, Yang M. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med. 2003;31:337-354.
10. Yamaguchi-Miyamoto T, Kawasuji T, Kuraishi Y, Suzuki H. Antipruritic effects of Sophora flavescens on acute and chronic itch-related responses in mice. Biol Pharm Bull. 2003;26:722-724.
11. Ho-sub L, Kwan-Ha P, Kang-Beom K, Byeong-Sun M, Cheol- Min S, Yong-Seon S, et al. Anti-allergic activity of the Sophorae radix water extract in experimental animals. Am J Chin Med. 2001;29:129-139.
12. Xu GL, Yao L, Rao SY, Gong ZN, Zhang SQ, Yu SQ. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. J Ethnopharmacol. 2005;98:177-183.
13. Piao XL, Piao XS, Kim SW, Park JH, Kim HY, Cai SQ. Identification and characterization of antioxidants from Sophora flavescens. Biol Pharm Bull. 2006;29:1911-1915.
14. Ling JY, Zhang GY, Cui ZJ, Zhang CK. Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography. J Chromatogr A. 2007;1145:123-127.
15. Chen X, Yi C, Yang X, Wang X. Liquid chromatography of active principles in Sophora flavescens root. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;812:149-163.
16. Li K, Wang H. Simultaneous determination of matrine, sophoridine and oxymatrine in Sophora flavescens Ait by high performance liquid chromatography. Biomed Chromatogr. 2004; 18:178-182.
17. Ban M, Morel G, Langonne I, Huguet N, Pepin E, Binet S. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology. 2006;218:39-47.
18. Abe Y, Takeda N, Irifune M, Ogino S, Kalubi B, Imamura I, et al. Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. Acta Oto-Laryngol. 1992;112:703-709.
19. Kalubi B, Takeda N, Irifune M, Ogino S, Abe Y, Su-Ling H, et al. Nasal mucosa sensitization with toluene diisocyanate (TDI) increases peprotachykinin A (PPTA) and preproCGRP mRNA in guinea pig trigeminal ganglion neurons. Brain Res. 1992;576:287-296.
20. Takeda N, Morita M, Hasegawa S, Horii A, Kubo T, Matsunaga T. Neuropharmacology of motion sickness and emesis. A review. Acta Otolarygol. 1993;Suppl 501:10-15.
21. Abe Y, Ogina S, Irifune M, Imamura I, Liu YQ, Fukui H, et al. Histamine content, synthesis and degradation in nasal mucosa and lung of guinea-pigs treated with toluene diisocyanate (TDI). Clin Exp Allergy. 1993;23:512-517.
22. Kitamura Y, Miyoshi A, Murata Y, Kalubi B, Fukui H, Takeda N. Effect of glucocorticoid on up-regulation of H1R mRNA in nasal mucosa of rats sensitized by exposure to toluene diisocyanate. Acta Oto-Laryngol. 2004;124:1053-1058.
23. Murata Y, Miyoshi A, Kitamura Y, Takeda N, Fukui H. Upregulation of H1Rs in an allergic rat nasal mucosa model. Inflamm Res. 2004;53:11-12.
24. Tanaka K, Okamoto Y, Nagata Y, Nishimura F, Takeoka A, Hanada S, et al. A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate. Int Arch Allergy Appl Immunol. 1988;85:392-397.
25. The Japanese Practical Guideline of Allergic Rhinitis, The Rheumatism and Allergy Information Center. Available from http://www.allergy.go.jp/allergy/ guideline/04/index.html
26. Irifune M. [Effect of sympathetic denervation in guinea pigs with nasal hypersensitivity.] Jibirinnsho. 1989;82:719-727. (in Japanese)
27. Mapp C, Boschetto P, Miotto D, De Rosa E, Fabbri LM. Mechanisms of occupational asthma. Ann Allergy Asthma Immunol. 1999;83:645-664.
28. Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol. 2001;1: 169-175.
29. Maestrelli P, Saetta M, Mapp C, Fabbri LM. Diagnostic basis of occupational asthma. J Investig Allergol Clin Immunol. 1997;7: 316-317.
30. Kitamura Y, Das AK, Murata Y, Maeyama K, Dev S, Wakayama Y, et al. Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats. Allergol Int. 2006;55:279-286.
31. Dev S, Mizuguchi H, Das AK, Matsushita C, Maeyama K, Umehara H, et al. Suppression of histamine signaling by probiotic Lac-B: a possible mechanism of its anti-allergic effect. J Pharmacol Sci. 2008;107:159-166.
32. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997;49:253-278.
33. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem. 2000;275:36781-36786.
34. Nakasaki T, Masuyama K, Fukui H, Ogino S, Eura M, Samejima Y, et al. Effects of PAF on histamine H1 receptor mRNA expression in rat trigeminal ganglia. Prostaglandins Other Lipid Mediat. 1999;58:29-41.
35. Bryce PJ, Mathias CB, Harrison KL, Watanabe T, Geha RS, Oettgen HC. The H1 histamine receptor regulates allergic lung responses. J Clin Invest. 2006;116:1624-1632.
36. Iriyoshi N, Takeuchi K, Yuta A, Ukai K, Sakakura Y. Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy. 1996;26:379-385.
37. Hamano N, Terada N, Maesaka K, Ikeda T, Fukuda S, Wakita J, et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells-the effects of sex hormones. Int Arch Allergy Immunol. 1998;115:220-227.
38. Hirata N, Takeuchi K, Ukai K, Sakakura Y. Expression of histidine decarboxylase messenger RNA and histamine Nmethyltransferase messenger RNA in nasal allergy. Clin Exp Allergy. 1999;29:76-83.
39. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul, WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701-738.
40. Martin JG, Suzuki M, Ramos-Barbon D, Isogai S. T cell cytokines: animal models. Paediatr Respir Rev. 2004;5:S47-S51.
41. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. IL-4 induces allergy like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990;62:457-467.
42. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. IL-13 central mediator of allergic asthma. Science. 1998;282:2258-2261.
43. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human must cells. Proc Natl Acad Sci U S A. 1999;96:8080-8085.
44. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002;26:202-208.
45. Hsieh FH, Lam BK, Penrose JF, Austen KF, Boyce JA. T helper cell type 2 cytokines coordinately regulate immunoglobulin Edependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by IL-4. J Exp Med. 2001;193:123-133.
46. Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol. 2003;112:S83-S88.
47. Igaz P, Novak I, Lazar E, Horvath B, Heninger E, Faauls A. Bidirectional communication between histamine and cytokines. Inflamm Res. 2001;50:123-128.
48. Abdelaziz M, Devalia J, Khair O, Bayram H, Prior A, Davies R. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 1998;101:410-420.
49. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol. 1999;162:5455-5465.
50. Lagier B, Lebel B, Bousquest J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-?) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol. 1997;108:545-551.
51. Krouwels FH, Hol BE, Lutter R, Bruinier B, Bast A, Jansen HM, et al. Histamine affects interleukin-4, interleukin-5, and interferon-? production by human T cell clones from airways and blood. Am J Respir Cell Mol Biol. 1998;18:721-730.
52. Ueno A, Morinaga K, Fukushima S, Iitaka Y, Koiso Y, Okuda S. Studies on Lupin Alkaloides. VI. Isolation and structure of (+)- Isomatrine. Chem Pharm Bull (Tokyo). 1975;23:2560-2566.
53. Kawakami N, Miyoshi K, Horio S, Fukui H. Beta (2)-adrenergic receptor mediated histamine (1) receptor down-regulation: Another possible advantage of beta (2) agonists in asthmatic therapy. J Pharmacol Sci. 2004;94:449-458.
54. Yamada M, Watanabe T, Harino S, Fukui H, Wada H. The effects of protease inhibitors on histidine decarboxylase activities and assay of enzyme in various rat tissues. Biochem Biophys Acta. 1980;615:458-464.
55. Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr. 1985;344:115-123.
56. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol. 1990;86:599-605.
57. Bachert C. Histamine-a major role in allergy? Clin Exp Allergy. 1998;28 Suppl 6:15-19.
58. Howarth PH. Mediators of nasal blockage in allergic rhinitis. Allergy. 1997;52 Suppl 40:12-18.
59. Fukui H. Review of some molecular and physiological studies of histamine H1 receptor function (Hiroshi Wada Symposium). Inflamm Res. 2005;54:S52-S53.
60. Takeda N. [Neurogenic inflammation in nasal hyper reactivity.] Nihon Kyobu Shikkan Gakkai Zasshi. 1993;31:108-114. (in Japanese)
61. Dinh QT, Cryer A, Dinh S, Peiser C, Wu S, Springer J, et al. Transcriptional up-regulation of histamine receptor-1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis. Clin Exp Allergy. 2005;35:1443-1448.
62. Hamano N, Terada N, Maesaka K, Ikeda T, Fukuda S, Wakita J, et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells-the effects of sex hormones. Int Arch Allergy Immunol. 1998;115:220-227.
63. Baroody FM, Naclerio RM. Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55:17-27.
64. Yamauchi K. [Regulation of gene expression of L-histidine decarboxylase and histamine N-methyl-transferase, and its relevance to the pathogenesis of bronchial asthma.] Nippon Rinsho. 1996;54:377-388. (in Japanese)
65. Das AK, Yoshimura S, Mishima R, Fujimoto K, Mizuguchi H, Dev S, et al. Stimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcription. J Pharmacol Sci. 2007;103:374-382.
66. Mamessier E, Milhe F, Guillot C, Birnbaum J, Dupuy P, Lorec AM, et al. T-cell activation in occupational asthma and rhinitis. Allergy. 2007;62:162-169.
67. KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, Jung S, et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 2006; 118:1117-1125.
68. Woodfolk JA. Cytokines as a therapeutic target for allergic diseases: a complex picture. Curr Pharm Des. 2006;12:2349-2363.
69. Johnson VJ, Yucesoy B, Reynolds JS, Fluharty K, Wang W, Richardson D, et al. Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice. J Immunol. 2007;179:1864-1871.
70. Fukui H. Progress in allergy signal research on mast cells: upregulation of histamine signal-related gene expression in allergy model rats. J Pharmacol Sci. 2008;106:325-331.
71. Mizuguchi H, Hatano M, Matsushita C, Umehara H, Kuroda W, Kitamura Y, et al. Repeated pre-treatment with antihistamines supresses transcriptional up-regulations of histamine H1 receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats. J Pharmacol Sci. 2008;108:480-486.
72. Zenmyo M, Hiraoka K, Sasaguri T, Komiya S, Inoue A, Morimatsu M, et al. Interleukin-4 stimulates rheumatoid synovial fibroblasts to express matrix metalloproteinase-1 (tissue collagenase) and histamine H1 receptor mRNA. Biochem Mol Biol Int. 1996;40:1253-1260.
73. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol. 1992;90:699-704.
74. Durham SR. The ideal nasal corticosteroid: balancing efficacy, safety and patient preference. Clin Exp Allergy Rev. 2002;2:32-37.